
|Videos|July 27, 2021
How genomic testing can address accuracy issues with PSA screening and monitoring
Author(s)Urology Times staff
Advertisement
Brian T. Helfand, MD, PhD, NorthShore University HealthSystem, discusses how the precision of genomic testing data can alleviate the accuracy issues associated with PSA testing for screening and monitoring prostate cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Ac-225 rosopatamab tetraxetan shows promising activity in Lu-PSMA–pretreated mCRPC
2
FDA updates in urology: June 2026
3
Gopa Iyer, MD, highlights data on anti-Nectin-4 ADC for metastatic urothelial carcinoma
4
Economic analysis: SURE reduces downstream stone costs
5












